Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride
Product Images NDC 21695-820

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride (NDC 21695-820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (E4020ca3 82d0 4668 B4bc 92e4a53c1f4e 01)

FDA Label Image

Chemical Structure (E4020ca3 82d0 4668 B4bc 92e4a53c1f4e 02)

FDA Label Image

Fexofenadine HCl/pseudoephenadrine 60/120mg (E4020ca3 82d0 4668 B4bc 92e4a53c1f4e 03)

Fexofenadine HCl/pseudoephenadrine 60/120mg (E4020ca3 82d0 4668 B4bc 92e4a53c1f4e 03)
This is a product description for Fexofenadine HCI/Pseudoephedrine HCl ER Tablets, which are two-layer tablets containing 60mg of Fexofenadine HCI and 120mg of Pseudoephedrine HCI, made by Winthrop U.S., a business of sanofi-aventis U.S. LLC. The tablets are engraved with "WO7" on the white layer and have a clear film coating. These tablets are intended to be stored at controlled room temperature and kept out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.